Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling refers to a type of cell communication in which signaling molecules—such as growth factors, cytokines, and chemokines—are released by one cell to act on nearby cells, activating various signal transduction pathways. In the context of tissue regeneration and immunomodulation, paracrine signaling is essential for coordinating tissue repair, cellular differentiation, immune cell recruitment, and modulation of inflammatory responses. Common paracrine mediators include fibroblast growth factors (FGFs), Wnts, TGF-beta superfamily members, and others. These signals promote processes such as stem cell activation, proliferation, and differentiation, as well as immune cell function in response to injury or disease. Rather than a single entity, paracrine signaling encompasses a diverse and highly regulated set of pathways with significant roles in development, regeneration, and disease. Targeting paracrine signaling for therapeutic purposes often involves modulating individual growth factors, cytokine pathways, or their respective receptors rather than the general phenomenon itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling pathways involved in tissue regeneration and immunomodulation.